Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAMA: Vitamin D Supplementation for Prevention of Adverse Obstetric Outcomes in Uganda
NCT07510568Phase 4Not yet recruiting
- Sponsor
- St. Mary's Hospital Lacor
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of vitamin d in preeclampsia, eclampsia, HELLP syndrome (HELLP), sponsored by St. Mary's Hospital Lacor. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
vitamin d
03
Conditions
preeclampsiaeclampsiaHELLP syndrome (HELLP)
Beyond the preview
Go deeper on NCT07510568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07510568.